title: Ebola vaccine R&D: Filling the knowledge gaps.
abstract: With an emphasis on systems analyses, the VSV-EBOVAC project harnesses state-of-the-art technologies that illuminate mechanisms behind the observed immunogenicity and reactogenicity of the rVSV-ZEBOV vaccine and ensures that such information is shared among stakeholders.
authors.affiliation: Laboratorio di Microbiologia Molecolare e Biotecnologia (LA.M.M.B.), Dipartimento di Biotecnologie Mediche, Università di Siena, 53100 Siena, Italy. Sclavo Vaccines Association, 53100 Siena, Italy. donata.medaglini@unisi.it.
authors.forename: Donata
authors.initials: D
authors.lastname: Medaglini
authors.affiliation: Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 7A, Gothenburg, Sweden.
authors.forename: Ali M
authors.initials: AM
authors.lastname: Harandi
authors.affiliation: Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
authors.forename: Tom H M
authors.initials: TH
authors.lastname: Ottenhoff
authors.affiliation: Center for Vaccinology, Geneva University Hospitals and University of Geneva, 1211 Geneva, Switzerland.
authors.forename: Claire-Anne
authors.initials: CA
authors.lastname: Siegrist
mesh_terms: D000917:Antibody Formation / Q000276:immunology; D002986:Clinical Trials as Topic; D046129:Ebola Vaccines / Q000276:immunology*; D029043:Ebolavirus / Q000276:immunology; D006801:Humans; D019359:Knowledge; D012106:Research; D014611:Vaccination
chemical_list: D046129:Ebola Vaccines